The Australian National Cervical Screening Program (NCSP) was established in 1991, and resulted in a halving in the incidence and mortality of cervical cancer by the early years of this century.1 This outstanding achievement was due to an organised approach to screening by the coordinated efforts ...
Cervical screening: time to change the policy. Med J Aust. 2002 Jun 3;176(11):547-50. 117. Canfell K, Sitas F, Beral V. Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality. Med J Aust. 2006 Nov 6;185(...
To estimate the rate of cervical cancer screening in Western Australia in 1992, and any variation by age, place of residence, and socio-economic status; and to determine the proportion of smears taken by different service providers. Descriptive study; collection of data from Papanicolaou (Pap) sm...
HPV screening every 5 years. Furthermore, VIA generated more than double the number of pre-cancer treatments compared to HPV. In conclusion, primary HPV screening is the most effective, cost-effective and efficient cervical screening option in LMICs. These findings have directly informed WHO’s ...
New Tools for Cervical Cancer Screening JAMA Editorial August 21, 2018 Screening for Cervical Cancer JAMA JAMA Patient Page August 21, 2018 This JAMA Patient Page describes the US Preventive Services Task Force’s recommendations on screening for cervical cancer. Age of Initiation of Cervical Cancer...
Cervical Screening at Age 50–64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study BackgroundThere is little consensus, and minimal evidence, regarding the age at which to stop cervical screening. We studied the association between screen... ...
Only a dozen of HPV tests are considered as clinically validated for screening. The lower specificity of HPV test dictates the use of triage tests that can select women for colposcopy. Reflex cytology is currently the only well validated triage test; HPV genotyping and p16 immunostaining may be ...
Regarding the appropriate age of screening, the US Preventive Services Task Force suggests that women aged 21 to 29 years should be screened every three years with cytology alone and that women aged 30 to 65 years opt for cytology alone every three years, hr-HPV testing every five years, or...
Even after several negative smear results, age is not a good discriminative factor for early cessation of cervical cancer screening.Dr Radhika ThangaveluBMJ
Objective: We aimed to determine high risk HPV prevalence and its distribution by age groups. Risk factors, cytological, colposcopic and cervical biopsies results associated with high risk HPV infection in a sample of women who self referred for cervical cancer screening. Methods: In a cross ...